Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Epigenetic heterogeneity and transcriptional drivers of triple-negative breast cancer (PDX Methylation)

ABSTRACT: Epigenetic heterogeneity and transcriptional drivers of triple-negative breast cancer (PDX Methylation)

PROVIDER: PRJNA837239 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

Epigenetic heterogeneity and transcriptional drivers of triple-negative breast cancer (PDX RNA-Seq)

Project description:Epigenetic heterogeneity and transcriptional drivers of triple-negative breast cancer (PDX RNA-Seq)

| PRJNA837241 | ENA

Epigenetic heterogeneity and transcriptional drivers of triple-negative breast cancer (PDX H3K27ac ChIP-Seq)

Project description:Epigenetic heterogeneity and transcriptional drivers of triple-negative breast cancer (PDX H3K27ac ChIP-Seq)

| PRJNA837242 | ENA

Epigenetic heterogeneity and transcriptional drivers of triple-negative breast cancer

Project description:Epigenetic heterogeneity and transcriptional drivers of triple-negative breast cancer

| PRJNA837247 | ENA

Epigenetic heterogeneity and transcriptional drivers of triple-negative breast cancer (PDX Methylation)

Project description:Triple-negative breast cancer (TNBC) is a heterogeneous disease with limited treatment options. To characterize TNBC heterogeneity and treatment response, we combined functional and molecular profiling with computational analysis tools. Using these approaches, we defined transcriptional, epigenetic, and metabolic subtypes, and identified subtype-driving super-enhancers. Single cell RNA sequencing analyses revealed relative homogeneity of the three major transcriptional subtypes (luminal, basal and mesenchymal) within tumors. We found that mesenchymal TNBCs are more similar to mesenchymal neuroblastoma and rhabdoid tumors than to other TNBC subtypes, and the PRRX1 transcription factor serves as a key driver of these tumors. By directly regulating the transcription of mesenchymal genes, PRRX1 is sufficient for inducing the mesenchymal subtype but is not required for its maintenance.

2023-11-09 | GSE202775 | GEO

Epigenetic heterogeneity and transcriptional drivers of triple-negative breast cancer [RNA-Seq]

Project description:Epigenetic heterogeneity and transcriptional drivers of triple-negative breast cancer [RNA-Seq]

| PRJNA970796 | ENA

Epigenetic heterogeneity and transcriptional drivers of triple-negative breast cancer [ChIP-Seq]

Project description:Epigenetic heterogeneity and transcriptional drivers of triple-negative breast cancer [ChIP-Seq]

| PRJNA970798 | ENA

Epigenetic heterogeneity and transcriptional drivers of triple-negative breast cancer (PDX RNA-Seq)

2023-11-09 | GSE202773 | GEO

18 PDX of triple-negative breast cancer genotyped with SNP6 Affymetrix arrays

Project description:To characterize Homologous recombination deficiency (BRCAness) in triple-negative breast cancer PDX models genomic signature was utilized. After normalization using Genotyping Console we obtained absolute copy number profiles using the GAP software (Popova et al, Genome Biol, 2009). The number of Large-scale State Transitions (LSTs) was used to annotate PDX as BRCAness or not (Popova et al, Cancer Res 2012).

2020-01-01 | E-MTAB-8654 | biostudies-arrayexpress

22 PDX of triple-negative breast cancer genotyped with Affymetrix Cytoscan HD

Project description:To characterize Homologous recombination deficiency (BRCAness) in triple-negative breast cancer PDX models genomic signature was utilized. After normalization using ChAS we obtained absolute copy number profiles using the GAP software (Popova et al, Genome Biol, 2009). The number of Large-scale State Transitions (LSTs) was used to annotate PDX as BRCAness or not (Popova et al, Cancer Res 2012).

2020-01-01 | E-MTAB-8653 | biostudies-arrayexpress

Epigenetic heterogeneity and transcriptional drivers of triple-negative breast cancer (PDX H3K27ac ChIP-Seq)

2023-11-09 | GSE202772 | GEO